搜索优化
Rewards
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
HealthDay on MSN
1 天
Adjuvant Pembrolizumab Improves Survival in Muscle-Invasive Urothelial Cancer
Disease-free survival is significantly longer with adjuvant pembrolizumab than observation among patients with high-risk ...
12 天
SystImmune, Inc. to Present New BL-B01D1 Data in Urothelial, Biliary Tract, and Esophageal ...
SystImmune, Inc. (SystImmune), a clinical-stage biotechnology company, today announced that three abstracts on BL-B01D1, a ...
UroToday
7 小时
IBCN 2024: Oncolytic Virotherapy Expressing a Novel TLR Agonist and IL-15 for the Treatment ...
In vivo, using the subcutaneous MB49 bladder cancer model, HSV5-15 virus expressing both the cytokine and TLR agonist ...
Medscape
3 天
Similar QoLs Seen With Immunotherapy + Chemo vs Chemo in Bladder Cancer
Researchers compared health-related quality of life with nivolumab added to first-line chemo vs chemo alone in patients with ...
Cure Today
1 天
Keytruda Improves Disease-Free Survival in Some With Urothelial Carcinoma
Among patients with high-risk muscle-invasive urothelial carcinoma, postsurgical Keytruda extended the time some lived ...
The American Journal of Managed Care
7 天
Enfortumab Vedotin Effective in Patients With Urothelial Cancer Outside of Clinical Trials
Enfortumab vedotin showed a robust disease control rate in patients with urothelial cancer outside of a clinical trial, and ...
Cure Today
3 天
Trodelvy May Improve Responses in Bladder Cancer Subtype
Trodelvy in locally advanced or metastatic urothelial cancer may provide another option for those whose disease progressed ...
7 天
2024ESMO 大咖E-talk | 叶定伟教授:向“难啃的硬骨头”发起冲击,泌尿 ...
为何EGFR/HER3双抗在尿路上皮癌中表现出出色的疗效信号,对于其分子机制的探索还有很长的路要走。从目前已知的机制来说:EGFR和HER3在膀胱癌中具有很高的表达率,且EGFR与HER3的激活或突变与肿瘤发展、耐药等密切相关。
Medscape
1 天
Expression of Histone Deacetylases 1, 2 and 3 in Urothelial Bladder Cancer
This is the first comprehensive immunohistochemical analysis of the expression of several class I HDAC proteins (1, 2 and 3) in urothelial carcinoma. In our study, we found all three isoforms in a ...
7 天
ESMO中国之声丨叶定伟教授团队多项研究荣登国际舞台,展示中国泌尿 ...
编者按: 2024年欧洲肿瘤内科学会(ESMO)年会于当地时间9月13日~17日在西班牙巴塞罗那召开。作为肿瘤学界的年度盛典,ESMO每年都会吸引上万名世界各地的肿瘤学大咖,为全球学者提供了良好的交流平台。今年, 复旦大学附属肿瘤医院叶定伟教授团队 ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈